UK Penny Stocks: 3 Picks With Market Caps Below £300M

In This Article:

The UK stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines due to weak trade data from China, highlighting global economic uncertainties. Amid these broader market movements, investors often look for opportunities in less prominent areas like penny stocks, which can still offer growth potential despite their niche status. These stocks, typically representing smaller or newer companies, may present compelling opportunities when supported by strong financial health and long-term potential.

Top 10 Penny Stocks In The United Kingdom

Name

Share Price

Market Cap

Financial Health Rating

Ultimate Products (LSE:ULTP)

£0.64

£54.07M

★★★★★☆

Next 15 Group (AIM:NFG)

£2.615

£260.08M

★★★★☆☆

Central Asia Metals (AIM:CAML)

£1.55

£269.66M

★★★★★★

Warpaint London (AIM:W7L)

£3.55

£286.79M

★★★★★★

Foresight Group Holdings (LSE:FSG)

£3.41

£386.35M

★★★★★★

Polar Capital Holdings (AIM:POLR)

£3.75

£361.49M

★★★★★★

Cairn Homes (LSE:CRN)

£1.60

£992.4M

★★★★★☆

Begbies Traynor Group (AIM:BEG)

£0.93

£148.32M

★★★★★★

QinetiQ Group (LSE:QQ.)

£3.91

£2.15B

★★★★★☆

Van Elle Holdings (AIM:VANL)

£0.34

£36.79M

★★★★★★

Click here to see the full list of 393 stocks from our UK Penny Stocks screener.

We'll examine a selection from our screener results.

AdvancedAdvT

Simply Wall St Financial Health Rating: ★★★★★★

Overview: AdvancedAdvT Limited offers software solutions across Europe, the United Kingdom, North America, and other international markets, with a market capitalization of £199.80 million.

Operations: The company's revenue segment is derived entirely from Blank Checks, totaling £31.68 million.

Market Cap: £199.8M

AdvancedAdvT Limited, with a market cap of £199.80 million, recently became profitable and is trading significantly below its estimated fair value. The company operates without debt, which simplifies financial stability concerns. Its short-term assets comfortably cover both short- and long-term liabilities, indicating strong liquidity. Despite the recent profitability milestone, earnings have been influenced by a substantial one-off gain of £2.5 million in the last year. While the board has seasoned members with an average tenure of four years, the management team is relatively new with 1.3 years average tenure. Recent executive changes include the resignation of Non-Executive Director Mark Brangstrup Watts in February 2025.

AIM:ADVT Debt to Equity History and Analysis as at Apr 2025
AIM:ADVT Debt to Equity History and Analysis as at Apr 2025

Concurrent Technologies

Simply Wall St Financial Health Rating: ★★★★★★

Waiting for permission
Allow microphone access to enable voice search

Try again.